Search
Topiramate
go.drugbank.com/drugs/DB00273ApprovedInvestigational[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. … [L10550] Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.
Products: TOPIRAMATO EG, TOPIMOL 50 MG FİLM KAPLI TABLET, 120 ADETDenosumab
go.drugbank.com/drugs/DB06643ApprovedInvestigationalIt further received additional indication approval to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer and women at high risk … It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss.
Products: XGEVA® 120 MG/1.7 ML, Prolia Solution for Injection 60 mg/ml (Prefilled Syringe)Trazodone
go.drugbank.com/drugs/DB00656ApprovedInvestigational[T646] It was initially granted FDA approval in 1981.[L3484] … [T646] A unique feature of this drug is that it does not promote the anxiety symptoms, sexual symptoms, or insomnia, which are commonly associated with SSRI and SNRI therapy.
Products: DESYREL 100 MG FİLM KAPLI TABLET, 60 ADET, DESYREL 50 MG FİLM KAPLI TABLET, 60 ADETDihydrocodeine
go.drugbank.com/drugs/DB01551ApprovedIllicitIt was marketed in 1911. … It is semi-synthetic, and was developed in Germany in 1908 during an international search to find a more effective antitussive agent to help reduce the spread of airborne infectious diseases such as tuburculosis
Mixtures: Poly-tussin EXProducts: Codidol retard 120 mg - Filmtabletten, Dehace retard 120 mg - FilmtablettenGinkgo biloba
go.drugbank.com/drugs/DB01381ApprovedInvestigationalNutraceutical[A232404] EGb761 contains 6% terpene lactones and 24% flavonoid glycosides.[A232379] Flavonoids include quercetin, rutin, kaempferol, and isorhamnetin. … It is originally native to China, and _ginkgo biloba_ extract has been used in traditional Chinese medicine for centuries.
Mixtures: MEGINGO 10/120 MG EFERVESAN TABLET, 90 ADET, MEGINGO 20/120 MG EFERVESAN TABLET, 90 ADETProducts: BINKO 120 MG, TEBOKAN INTENS 120 MG TABLET, 30 ADETPertuzumab
go.drugbank.com/drugs/DB06366ApprovedInvestigationalIt consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. … It was first approved by the FDA in 2012 for use with [docetaxel] and another HER2-targeted monoclonal antibody, [trastuzumab], in the treatment of metastatic HER2-positive breast cancer.
Mixtures: PHESGO® 1200 MG/600 MG, PHESGO® 1200 MG/600 MGProducts: PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 1200 MG/600 MG / 15 ML, PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 600 MG/600 MG / 10 MLCiclesonide
go.drugbank.com/drugs/DB01410ApprovedInvestigationalIt is marketed under the brand name Alvesco.
Mixtures: LUXNID 2/200 MCG INHALASYON IÇIN TOZ IÇEREN KAPSÜL,120 KAPSÜL, LUXNID 2/400 MCG INHALASYON IÇIN TOZ IÇEREN KAPSÜL,120 KAPSÜLProducts: ALVESCO 160 UG 120 HUB, ALVESCO 160 MCG COZELTI ICEREN INHALASYON AERSOLU 60 DOZPiracetam
go.drugbank.com/drugs/DB09210ApprovedWithdrawnIt is not approved for any medical or dietary use by the FDA. … It shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid and is a cyclic derivative of the neurotransmitter γ-aminobutyric acid (GABA).
Products: NOOTROPIL INFUSION INTRAVENOSA 12G/ 60 ML, BIOCETAM KAPSÜL, 60 ADETAtropine
go.drugbank.com/drugs/DB00572ApprovedInvestigationalVet approvedIt is a racemic mixture of d-and l-hyoscyamine, of which only l-hyoscyamine is pharmacologically active. … [A251660,L42815,L42825,L42835] It has a variety of therapeutic applications, including pupil dilation and the treatment of anticholinergic poisoning and symptomatic bradycardia in the absence of reversible
Mixtures: LOMOTİL 2,5 MG + 0,025 MG / 5 ML ORAL ÇÖZELTİ, 60 ML, Me-PB-HyosProducts: ATROSOL EYE DROPS 10 mg/ml, ATROPINE SULFAT IE AMPUL 1 MG/ML, 10 ADETLacosamide
go.drugbank.com/drugs/DB06218ApprovedInvestigational[A262681] It was granted approval by Health Canada in September 2010.[L49206] … As a chiral functionalized amino acid, it works by blocking slowly inactivating components of voltage-gated sodium currents.
Mixtures: ELEPSİ 50 MG+100 MG TEDAVİYE BAŞLAMA PAKETİ, 42 ADET, ELEPSİ 50 MG+100 MG TEDAVİYE BAŞLAMA PAKETİ, 42 ADETProducts: LACOSAMIDE EG, BENVIDA 10 MG/ML IV INFUZYON COZELTISI, 20 ML